These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2316020)

  • 1. A novel sulphate conjugate of cyclosporine occurring in high concentrations in vivo.
    Johansson A; Henricsson S; Möller E
    Transplantation; 1990 Mar; 49(3):619-22. PubMed ID: 2316020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
    Bowlin TL; Rosenberger AL; McKown BJ
    Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
    Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
    J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
    Kasaian MT; Biron CA
    J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.
    Bubeck R; Miethke T; Heeg K; Wagner H
    Eur J Immunol; 1989 Apr; 19(4):625-30. PubMed ID: 2499483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic properties of a sulphate conjugate of cyclosporine A.
    Johansson A; Henricsson S; Möller E
    Transplant Proc; 1990 Feb; 22(1):213. PubMed ID: 2309318
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cyclosporine on secondary cytotoxic T lymphocyte responses.
    Kiziroglu F; Miller RG
    Transplantation; 1990 May; 49(5):961-5. PubMed ID: 2139987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine.
    Noble RL; Steinmuller D
    Transplantation; 1989 Feb; 47(2):322-6. PubMed ID: 2784016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1991 Apr; 51(4):851-7. PubMed ID: 2014542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of an obligate role for IFN-gamma in the primary in vitro mixed lymphocyte response.
    Bucy RP; Hanto DW; Berens E; Schreiber RD
    J Immunol; 1988 Feb; 140(4):1148-52. PubMed ID: 2963862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense.
    Thomas PT; House RV; Bhargava HN
    Life Sci; 1993; 53(18):1417-27. PubMed ID: 8231630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.